Clinical trial · no report yet · Phase 1/Phase 2
STARLiT
STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer
- NCT06574880 ↗
- Recruiting
- Angela Y. Jia, MD PhD
- Focused
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Preliminary discovery
Commentary in our index that names this trial so far
Podcasts, YouTube videos and X posts we have indexed. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build.
| Channel | Found | |
|---|---|---|
| X threads | 3 | |
| Podcasts | 1 |
The trial
ClinicalTrials.gov- Official title
- STARLiT: STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer: A Phase I/II Trial
- Phase
- Phase 1/Phase 2
- Status
- Recruiting
- Conditions
- Malignant Neoplasm of Prostate; Locally Advanced Prostate Cancer
- Interventions
- Lu-PSMA-617; 5-fraction Stereotactic Body Radiation Therapy (SBRT)
- Arms
- Lu-PSMA-617 + SBRT · Experimental
- Enrollment
- 45 (estimated)
- Primary outcomes
- Phase I: Maximum tolerated dose (MTD) of Lu-PSMA-617
- Phase II: Androgen deprivation therapy (ADT)-free survival
- Sponsor
- Angela Y. Jia, MD PhD
- Start
- May 13, 2025
- Primary completion
- Sep 1, 2026 (estimated)
- Results posted
- No
- Registry record
- NCT06574880 · updated May 26, 2026